PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

被引:0
作者
Humbert, M. [1 ]
Mclaughlin, V. V. [2 ]
Gibbs, S. R. [3 ]
Gomberg-Maitland, M. [4 ]
Hoeper, M. [5 ]
Preston, I. R. [6 ]
Souza, R. [7 ]
Waxman, A. B. [8 ]
Ghofrani, H. A. [9 ]
Subias, P. Escribano [10 ]
Feldman, J. P. [11 ]
Bohns Meyer, G. [12 ]
Montani, D.
Olsson, K. M.
Manimaran, S. [13 ]
Pena, J. de Oliveira [13 ]
Badesch, D. B. [14 ]
机构
[1] Hop Bicetre, Pneumol, Le Kremlin Bicetre, France
[2] Univ Michigan Hosp, Ann Arbor, MI 48109 USA
[3] Imperial Coll London, London, England
[4] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA
[5] Hannover Med Sch, Dept Resp Med, Hannover, Germany
[6] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA
[7] Univ Sao Paulo, Pulm Div Heart Inst, Med Sch, Sao Paulo, Brazil
[8] Brigham & Womans Hosp, Div Pulm & Crit Care Med, Boston, MA USA
[9] Univ Hosp Giessen & Marburgh GmbH, Giessen, Germany
[10] Hosp Univ 12 Octubre, Madrid, Spain
[11] Arizona Pulm Specialists, Phoenix, AZ USA
[12] Ctr Hipertensao Pulmonar, Porto Alegre, RS, Brazil
[13] Acceleron Pharma Inc, Cambridge, MA USA
[14] Univ Colorado, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2150
引用
收藏
页数:2
相关论文
empty
未找到相关数据